Literature DB >> 31199457

Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.

Jocelyne Piret1, Manuel Schibler2, Van Dung Pham3,4, Sébastien Hantz5,6,7, Federica Giannotti8, Stavroula Masouridi-Levrat8, Laurent Kaiser2, Nathalie Goyette1, Sophie Alain5,6,7, Rong Shi3,4, Guy Boivin1.   

Abstract

We report a case of cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient. A previously uncharacterized V787E mutation in UL54 was identified in cerebrospinal fluid but not plasma specimens. For the V787E recombinant virus, the half maximal effective concentrations for ganciclovir, foscarnet, and cidofovir were 8.6-, 3.4- and 2.9-fold higher than for wild-type virus, and the replicative capacity was lower. The introduction of a bulkier and negatively charged glutamate residue at position 787 could destabilize the finger domain of UL54 DNA polymerase. Viral genotyping of cerebrospinal fluid is warranted in subjects with cytomegalovirus encephalitis, owing to the low penetration of antivirals in this compartment.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cytomegalovirus; cerebrospinal fluid; compartmentalization; drug resistance; encephalitis; hematopoietic stem cell transplantation; recombinant phenotyping; replicative capacity; three-dimensional modeling

Mesh:

Substances:

Year:  2019        PMID: 31199457      PMCID: PMC6743826          DOI: 10.1093/infdis/jiz298

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.

Authors:  S K Seo; A Regan; T Cihlar; D C Lin; F Boulad; D George; V K Prasad; T E Kiehn; B Polsky
Journal:  Clin Infect Dis       Date:  2001-09-26       Impact factor: 9.079

2.  Crystal structure of the herpes simplex virus 1 DNA polymerase.

Authors:  Shenping Liu; John D Knafels; Jeanne S Chang; Gregory A Waszak; Eric T Baldwin; Martin R Deibel; Darrell R Thomsen; Fred L Homa; Peter A Wells; Monica C Tory; Roger A Poorman; Hua Gao; Xiayang Qiu; Andrew P Seddon
Journal:  J Biol Chem       Date:  2006-04-24       Impact factor: 5.157

3.  Three-dimensional modeling of cytomegalovirus DNA polymerase and preliminary analysis of drug resistance.

Authors:  Rong Shi; Arezki Azzi; Christian Gilbert; Guy Boivin; Sheng-Xiang Lin
Journal:  Proteins       Date:  2006-08-01

4.  Cytomegalovirus ventriculoencephalitis with compartmentalization of antiviral-resistant cytomegalovirus in a T cell-depleted haploidentical peripheral blood stem cell transplant recipient.

Authors:  Tae-Dong Jeong; Heungsup Sung; Sang-Ho Choi; Sang-Oh Lee; Hye-Kyung Yoon; Mi-Na Kim; Ho Joon Im
Journal:  Diagn Microbiol Infect Dis       Date:  2012-08-24       Impact factor: 2.803

5.  Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes.

Authors:  T Eckle; L Prix; G Jahn; T Klingebiel; R Handgretinger; B Selle; K Hamprecht
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

Review 6.  CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency.

Authors:  S M Reddy; D J Winston; M C Territo; G J Schiller
Journal:  Bone Marrow Transplant       Date:  2010-03-01       Impact factor: 5.483

7.  Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.

Authors:  Adriana Weinberg; Douglas A Jabs; Sunwen Chou; Barbara K Martin; Nell S Lurain; Michael S Forman; Clyde Crumpacker
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

8.  Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient.

Authors:  J E Julin; J H van Burik; W Krivit; C Webb; C J Holman; H B Clark; H H Balfour
Journal:  Transpl Infect Dis       Date:  2002-12       Impact factor: 2.228

9.  Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients.

Authors:  Dana G Wolf; Nell S Lurain; Tsila Zuckerman; Ron Hoffman; Judith Satinger; Alik Honigman; Niveen Saleh; Emanuel S Robert; Jacob M Rowe; Zipora Kra-Oz
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

10.  Structural basis of high-fidelity DNA synthesis by yeast DNA polymerase delta.

Authors:  Michael K Swan; Robert E Johnson; Louise Prakash; Satya Prakash; Aneel K Aggarwal
Journal:  Nat Struct Mol Biol       Date:  2009-08-30       Impact factor: 15.369

View more
  3 in total

1.  Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.

Authors:  Karima Zarrouk; Van Dung Pham; Jocelyne Piret; Rong Shi; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

2.  Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.

Authors:  Karima Zarrouk; Xiaojun Zhu; Van Dung Pham; Nathalie Goyette; Jocelyne Piret; Rong Shi; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

3.  Cytomegalovirus Infection and the Implications of Drug-Resistant Mutations in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Retrospective Study from a Tertiary Hospital in China.

Authors:  Uet Yu; Xiaodong Wang; Xiaoling Zhang; Chunjing Wang; Chunlan Yang; Xiaohui Zhou; Yue Li; Xiaochan Huang; Jing Wen; Feiqiu Wen; Sixi Liu
Journal:  Infect Dis Ther       Date:  2021-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.